DAVITA INC. — Director's Dealing 2016

Jul 13, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2016-07-11

Reporting Person: JIGANTI JEANINE MARIE (Chief Compliance Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-07-11	Common Stock	M	938	$48.68	Acquired	5716	Direct
2016-07-11	Common Stock	F	585	$78.07	Disposed	5131	Direct
2016-07-11	Common Stock	S	353	$78.5118	Disposed	4478	Direct
2016-07-11	Common Stock	S	938	$78.5131	Disposed	3840	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-11	Stock Appreciation Rights	$48.68	M	938	Disposed	2017-07-09	Common Stock (938)	Direct

Footnotes

F1: The exercise and sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2016.

F2: Represents the weighted average sale price of $78.5118. The range of prices for the sale of these shares was $78.49 - $78.53, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3: Represents the weighted average sale price of $78.5131. The range of prices for the sale of these shares was $78.49 - $78.52, rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F4: The Stock Appreciation Rights were granted on 7/9/2012. 25% vested on 7/9/2013, then 6.25% vested every three months thereafter.